Rubone is a chalcone analog that acts as a modulator of miR-34a. It upregulates miR-34a expression in a p53-dependent manner, downregulates the expression of downstream targets Bcl-2 and cyclin D1, and inhibits the growth of hepatocellular carcinoma (HCC) in vivo. Additionally, Rubone enhances the anticancer efficacy of paclitaxel (PTX) in PTX-resistant prostate cancer cell lines by reversing the expression of miR-34a downstream targets.